PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
349,500
0.00 (0.00%)
At close: Feb 27, 2026
Market Cap3.63T +43.5%
Revenue (ttm)496.03B +56.5%
Net Income151.24B +70.4%
EPS14,523.95 +80.6%
Shares Out10.39M
PE Ratio24.06
Forward PE17.85
Dividend1,100.00 (0.31%)
Ex-Dividend DateDec 29, 2025
Volume94,428
Average Volume243,253
Open346,500
Previous Close349,500
Day's Range344,000 - 352,500
52-Week Range289,500 - 713,000
Beta0.63
RSI39.47
Earnings DateFeb 4, 2026

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 497
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.

Financial Statements